Pruritus
Information
- Disease name
- Pruritus
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04950127 | Active, not recruiting | Phase 3 | Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) | August 27, 2021 | January 8, 2025 |
| NCT05525520 | Active, not recruiting | Phase 2 | Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis | October 6, 2022 | September 2024 |
| NCT05448170 | Available | Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC) | |||
| NCT00257582 | Completed | Phase 3 | Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics | August 2005 | |
| NCT00261079 | Completed | Phase 4 | Fexofenadine in Pruritic Skin Disease | April 2005 | October 2006 |
| NCT00330343 | Completed | Phase 2 | Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents | May 2004 | June 2009 |
| NCT00442819 | Completed | Phase 4 | Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial Kidney | July 2006 | September 2006 |
| NCT00568204 | Completed | N/A | Study of Effectiveness of Mexyn-A | March 2002 | September 2005 |
| NCT00745199 | Completed | Phase 2 | Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus | May 2008 | June 2009 |
| NCT00762983 | Completed | Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) | March 2008 | February 2009 | |
| NCT00782054 | Completed | Phase 4 | Evaluation of Post Burn Rehabilitation Population for Itch Control | September 2006 | April 2008 |
| NCT00884325 | Completed | Phase 4 | Management of Pruritus With Xyzal in Atopic Dermatitis | February 2009 | January 2010 |
| NCT01055236 | Completed | Phase 4 | Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients | August 2007 | October 2008 |
| NCT01071057 | Completed | Phase 2/Phase 3 | Naloxone for the Treatment of Opioid-Induced Pruritus | December 2010 | April 2013 |
| NCT01232985 | Completed | Phase 2 | Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults | October 2010 | December 2010 |
| NCT01236859 | Completed | N/A | Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus | September 2009 | November 2010 |
| NCT04706975 | Completed | Phase 2 | Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT) | January 11, 2021 | June 30, 2022 |
| NCT00058903 | Completed | Phase 2 | Treatment of Cholestatic Pruritus With Sertraline | April 2003 | March 2005 |
| NCT00215280 | Completed | N/A | Epidemiology and Control of Mansonella Perstans Infection in Uganda | November 2005 | February 2006 |
| NCT03477058 | Completed | N/A | In-Use Test With a Cosmetic Product to Treat Pruritus | January 23, 2017 | February 6, 2017 |
| NCT03483870 | Completed | Phase 2 | Effect of Granisetron on Morphine Induced Pruritus in Cesarean Section | June 1, 2018 | October 30, 2020 |
| NCT03490877 | Completed | Scratch and Sleep Quantification in Atopic Dermatitis | July 13, 2018 | September 30, 2019 | |
| NCT03546816 | Completed | Phase 3 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | May 2, 2018 | February 14, 2020 |
| NCT03617536 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus | July 5, 2018 | November 14, 2019 |
| NCT03673878 | Completed | Prevalence of a Localized or Diffuse Pruritus in a Population With One or Several, Primitive or Secondary, Brain Tumor(s) | June 29, 2020 | September 5, 2021 | |
| NCT03677401 | Completed | Phase 3 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | August 29, 2018 | February 6, 2020 |
| NCT03701971 | Completed | N/A | Study Evaluating the Benefit of Music Therapy on Pruritus in Patients With Pruritic Dermatitis | November 8, 2018 | April 19, 2019 |
| NCT03796052 | Completed | N/A | Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients | May 23, 2019 | December 18, 2019 |
| NCT03798561 | Completed | Phase 1 | Study to Evaluate ASN008 Topical Gel (TG) | January 14, 2019 | March 20, 2020 |
| NCT03824886 | Completed | N/A | Enhancing SKIN Health and Safety in Aged CARE | October 1, 2018 | June 4, 2021 |
| NCT03832140 | Completed | Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy | May 24, 2019 | November 19, 2019 | |
| NCT03841331 | Completed | Phase 2 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin | January 22, 2019 | January 21, 2020 |
| NCT03857568 | Completed | Phase 1 | A Trial of SHR0410 Injection in Hemodialysis Participants. | April 15, 2019 | November 8, 2019 |
| NCT03928223 | Completed | The Color of Itch; Itch Modification by Color Viewing | March 1, 2017 | August 31, 2018 | |
| NCT03997851 | Completed | Phase 1/Phase 2 | Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects | July 22, 2019 | March 18, 2020 |
| NCT04018027 | Completed | Phase 2 | Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis | June 29, 2019 | April 1, 2021 |
| NCT04099927 | Completed | Phase 1 | A Study of SHR4010 in Patients With Hemodialysis | July 28, 2019 | June 15, 2020 |
| NCT04289038 | Completed | N/A | The Efficacy of VR and AR on Pruritus | April 1, 2021 | February 26, 2022 |
| NCT04326738 | Completed | Early Phase 1 | The Effect of Midazolam on Dexamethasone-induced Perineal Pruritus | January 16, 2020 | December 30, 2020 |
| NCT04337073 | Completed | Early Phase 1 | The Effect of Propofol on Dexamethasone-induced Perineal Pruritus | September 1, 2020 | November 30, 2020 |
| NCT04365244 | Completed | Pruritus and Melanoma and Cutaneous Carcinomas Treated With Immunotherapy | August 19, 2019 | November 22, 2019 | |
| NCT04396977 | Completed | N/A | Inter-arm and Inter-period Reproducability of the Dermal Blood Flow Response After a Histamine Skin Prick. | February 28, 2019 | May 7, 2019 |
| NCT04399148 | Completed | N/A | Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin. | June 11, 2019 | September 23, 2019 |
| NCT04399213 | Completed | N/A | Dermal Blood Flow Response to Escalating Doses of Histamine, Administered by a Skin Prick | January 15, 2019 | February 19, 2019 |
| NCT04399525 | Completed | N/A | Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin. | October 28, 2019 | March 12, 2020 |
| NCT04415034 | Completed | Scalp Pruritus Measurement Using Visual Analog Scale and 5-d Itch Scale in Children With Pediculosis Capitis | September 1, 2018 | September 30, 2018 | |
| NCT04510090 | Completed | Phase 1 | Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus | September 7, 2020 | July 8, 2021 |
| NCT00058890 | Completed | Phase 3 | Gabapentin to Treat Itch in Patients With Liver Disease | November 2000 | January 2004 |
| NCT04745429 | Completed | N/A | Non-pharmacological Mitigation of Psoriasis | February 19, 2020 | October 6, 2020 |
| NCT04999787 | Completed | Phase 2 | A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus | September 16, 2021 | August 3, 2022 |
| NCT05038982 | Completed | Phase 2 | Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin | September 9, 2021 | July 11, 2022 |
| NCT05133830 | Completed | Phase 1 | Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants | November 23, 2021 | May 31, 2022 |
| NCT05180968 | Completed | Phase 3 | DIalysis Symptom COntrol-Pruritus Outcome Trial | August 2, 2022 | August 11, 2023 |
| NCT05287724 | Completed | Early Phase 1 | Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli | June 19, 2022 | January 4, 2024 |
| NCT05393076 | Completed | Phase 1 | Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls | July 19, 2022 | December 6, 2022 |
| NCT05435170 | Completed | Phase 1 | Food Effect Study of Linerixibat Tablets in Healthy Adult Participants | August 11, 2022 | October 10, 2022 |
| NCT05461456 | Completed | Phase 1 | Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% | April 1, 2022 | October 16, 2022 |
| NCT05634083 | Completed | N/A | Does Indoxyl Sulfate Have a Role in Uremic Pruritus? | November 25, 2022 | January 22, 2023 |
| NCT05659823 | Completed | Phase 4 | Postoperative Pain After Caesarian Section | November 2, 2020 | November 5, 2021 |
| NCT05750875 | Completed | Phase 4 | Gabapentin Versus Loratadine in Uremic Pruritus | May 1, 2022 | October 31, 2022 |
| NCT05870865 | Completed | Phase 2 | A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis | May 3, 2023 | December 28, 2023 |
| NCT01586091 | Completed | Phase 4 | Safety Study of Levocetirizine and Fexofenadine | February 2011 | February 2012 |
| NCT01727180 | Completed | Pruritus in Patients With Chronic Kidney Disease | June 2011 | December 2013 | |
| NCT01795079 | Completed | N/A | Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury | January 2013 | April 15, 2020 |
| NCT01897428 | Completed | Phase 1 | PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg | April 2011 | August 2011 |
| NCT01905631 | Completed | Phase 2 | Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus | July 2013 | September 2013 |
| NCT01919944 | Completed | Phase 1 | Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P | August 2013 | November 2013 |
| NCT01963793 | Completed | Phase 2 | Topical Aprepitant in Prurigo Patients | October 2013 | July 2014 |
| NCT02001948 | Completed | Phase 4 | Intrathecal Morphine for Inguinal Hernia Repair. | July 2009 | July 2010 |
| NCT02008864 | Completed | N/A | Evaluating the Effect of Senna in Uremic Pruritus | August 2011 | |
| NCT02143648 | Completed | Phase 2/Phase 3 | Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus | June 2014 | July 2015 |
| NCT02143973 | Completed | Phase 2/Phase 3 | Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus | September 2014 | January 2016 |
| NCT02174419 | Completed | Phase 2/Phase 3 | Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis | March 2015 | August 2016 |
| NCT02229929 | Completed | Phase 2 | Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus | July 2014 | July 2015 |
| NCT02277678 | Completed | Phase 3 | Comparison of Epidural Oxycodone and Epidural Morphine | August 2013 | December 2014 |
| NCT02475447 | Completed | Phase 2 | Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis | July 2015 | June 2017 |
| NCT02558738 | Completed | Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations | June 2015 | September 2015 | |
| NCT02639052 | Completed | Phase 1/Phase 2 | Itch Relieving Effect of Botox: a Study in Healthy Subjects | February 2016 | January 2017 |
| NCT02650076 | Completed | Phase 1 | A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects | January 2016 | |
| NCT02653703 | Completed | N/A | L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain | October 2014 | December 2014 |
| NCT02654483 | Completed | Phase 2 | Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients | August 31, 2016 | July 27, 2018 |
| NCT02671162 | Completed | Phase 2 | Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus | July 2015 | January 2016 |
| NCT02769910 | Completed | Phase 1/Phase 2 | Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch | May 2016 | July 2016 |
| NCT02793843 | Completed | N/A | Ondansetron vs Ondansetron Plus Dexamethasone for Relieving Intrathecal Morphine Side Effects After C-section | June 2016 | July 30, 2017 |
| NCT02823067 | Completed | Pruritus and Pemphigoid in Nursing Home Patients | June 1, 2016 | January 1, 2018 | |
| NCT02846181 | Completed | Phase 1 | A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405 | July 2016 | August 2016 |
| NCT02975206 | Completed | Phase 2 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis | November 2016 | February 23, 2018 |
| NCT03035942 | Completed | Phase 4 | Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration | January 2, 2017 | November 4, 2019 |
| NCT03209427 | Completed | Phase 4 | Serum Serotonin and Pruritus After Intrathecal Morphine in Cesarean Section | April 2, 2014 | September 21, 2016 |
| NCT03290989 | Completed | Itch and Pain Characteristics in Skin Carcinomas | April 1, 2015 | July 31, 2015 | |
| NCT03297580 | Completed | Itch and Clinacal Caracteristics in Systemic Sclerosis | February 1, 2016 | March 31, 2016 | |
| NCT03317301 | Completed | Phase 3 | Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus | May 17, 2017 | January 30, 2018 |
| NCT03322137 | Completed | Phase 2 | Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris | October 10, 2017 | October 22, 2018 |
| NCT03343639 | Completed | Phase 2 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis | November 1, 2017 | November 12, 2018 |
| NCT03448081 | Completed | Phase 2 | Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene | February 12, 2018 | December 10, 2018 |
| NCT03458572 | Completed | N/A | Acupuncture for Prevention of Itch in Caesarean Section | February 12, 2018 | November 15, 2018 |
| NCT05678309 | Not yet recruiting | Establishment of a Patient Library in Patients With Pruritus Sine Materia | April 1, 2023 | February 1, 2033 | |
| NCT06435299 | Not yet recruiting | Phase 3 | Efficacy and Tolerance of Cannabidiol in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study | July 1, 2024 | September 28, 2024 |
| NCT06290375 | Not yet recruiting | Phase 2 | A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population. | March 8, 2024 | April 11, 2025 |
| NCT04805073 | Recruiting | Phase 4 | Treatment of Pruritus With Intramuscular Promethazine | August 9, 2021 | June 30, 2025 |
| NCT06334679 | Recruiting | N/A | The Effect of Cold Gel Pack Application on Itching in Burn Patients in the Maturation Stage | January 15, 2024 | December 15, 2024 |
| NCT05779150 | Recruiting | N/A | Efficacy of CeraVe® Moisturizing Cream on Skin Pruritus in Elderly Patients | February 26, 2023 | February 3, 2024 |
| NCT05263206 | Recruiting | Phase 3 | Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) | February 15, 2022 | October 3, 2025 |
| NCT05978063 | Recruiting | Phase 2/Phase 3 | Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica | August 1, 2023 | May 2026 |
| NCT04256759 | Recruiting | Phase 2 | Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus | September 1, 2020 | May 2025 |
| NCT06120907 | Recruiting | Swiss Itch Registry | October 18, 2023 | October 2033 | |
| NCT06225323 | Recruiting | N/A | Effect of Lidocaine Infusion on Neuraxial Opioid-induced Pruritus After Cesarean Section | January 29, 2024 | May 1, 2024 |
| NCT05500794 | Recruiting | N/A | Meditation in Inflammatory Dermatosis | November 15, 2022 | May 15, 2025 |
| NCT06446609 | Recruiting | Drug-induced Liver Injury: Itching Study | June 14, 2024 | May 2028 | |
| NCT05604469 | Recruiting | The Role of Skin Microbiota in Hepatic or Renal Pruritus | October 1, 2022 | June 1, 2023 | |
| NCT01625455 | Terminated | Phase 4 | Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome | February 2012 | July 2016 |
| NCT03262038 | Terminated | Phase 4 | Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients? | December 7, 2017 | August 20, 2019 |
| NCT03540160 | Terminated | Phase 3 | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) | March 15, 2018 | June 17, 2020 |
| NCT01825655 | Terminated | Phase 4 | Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching | September 2014 | November 2017 |
| NCT03096444 | Terminated | Phase 2 | Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine | May 23, 2017 | July 21, 2017 |
| NCT05342623 | Terminated | Phase 3 | A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus | May 17, 2022 | February 29, 2024 |
| NCT02975271 | Terminated | Phase 2 | Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury | November 2016 | January 17, 2017 |
| NCT05356403 | Terminated | Phase 3 | CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus | August 26, 2022 | February 26, 2024 |
| NCT05387707 | Terminated | Phase 3 | Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis | August 16, 2022 | February 2, 2024 |
| NCT02247648 | Terminated | Phase 2 | Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy | June 2013 | December 2017 |
| NCT05024851 | Terminated | Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus | August 25, 2021 | July 8, 2022 | |
| NCT01605708 | Terminated | Phase 1/Phase 2 | Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis | June 2012 | April 2013 |
| NCT04317209 | Unknown status | Phase 1 | A Study of SHR0410 in Hemodialysis Patients With Pruritus | May 17, 2020 | December 2020 |
| NCT01769144 | Unknown status | N/A | Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh | January 2013 | April 2014 |
| NCT03340155 | Unknown status | N/A | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases | October 30, 2017 | October 2022 |
| NCT00715260 | Unknown status | An Observational Study of Pruritus Amongst Hemodialysis Patients | December 2007 | July 2008 | |
| NCT00577967 | Unknown status | N/A | Gabapentin - A Solution to Uremic Pruritus? | October 2005 | March 2006 |
| NCT04589429 | Unknown status | Phase 2 | Adding Nalbuphine for Control of Intrathecal Morphine Pruritus | October 15, 2020 | March 2021 |
| NCT02432508 | Unknown status | N/A | Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis | October 2014 | December 2016 |
| NCT04618146 | Unknown status | N/A | Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine. | November 10, 2020 | March 2021 |
| NCT05135390 | Unknown status | Phase 3 | A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients With Chronic Kidney Disease-Associated Pruritus | December 2021 | December 2022 |
| NCT03132142 | Unknown status | N/A | Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol | April 2017 | August 2017 |
| NCT01265082 | Unknown status | Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission | December 2010 | ||
| NCT04325802 | Withdrawn | Phase 2 | Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone | December 31, 2022 | June 2024 |
| NCT03464526 | Withdrawn | Phase 2 | A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis | May 2018 | October 2019 |
| NCT01801670 | Withdrawn | Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study | January 2015 | January 2015 | |
| NCT04154033 | Withdrawn | Phase 2 | Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone | October 1, 2020 | March 31, 2024 |
| NCT01092520 | Withdrawn | Phase 1 | Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children | July 2009 | July 2011 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000989
- ICD10 preferred id (Insert disease from ICD10)
- D0009733
- ICD10 class code (Insert disease from ICD10)
- L29
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011537